- Home
- STAA vs DFIN Comparison
STAA vs DFIN Comparison
Compare STAA & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- DFIN
- Stock Information
- Founded
- STAA 1982
- DFIN 1983
- Country
- STAA United States
- DFIN United States
- Employees
- STAA N/A
- DFIN N/A
- Industry
- STAA Ophthalmic Goods
- DFIN Other Consumer Services
- Sector
- STAA Health Care
- DFIN Consumer Discretionary
- Exchange
- STAA Nasdaq
- DFIN Nasdaq
- Market Cap
- STAA 850.9M
- DFIN 1.2B
- IPO Year
- STAA N/A
- DFIN N/A
- Fundamental
- Price
- STAA $17.17
- DFIN $64.27
- Analyst Decision
- STAA Hold
- DFIN Strong Buy
- Analyst Count
- STAA 8
- DFIN 3
- Target Price
- STAA $27.17
- DFIN $68.67
- AVG Volume (30 Days)
- STAA 746.9K
- DFIN 251.8K
- Earning Date
- STAA 08-06-2025
- DFIN 07-30-2025
- Dividend Yield
- STAA N/A
- DFIN N/A
- EPS Growth
- STAA N/A
- DFIN N/A
- EPS
- STAA N/A
- DFIN 3.01
- Revenue
- STAA $279,134,000.00
- DFIN $779,600,000.00
- Revenue This Year
- STAA N/A
- DFIN $1.99
- Revenue Next Year
- STAA $29.34
- DFIN $4.64
- P/E Ratio
- STAA N/A
- DFIN $21.56
- Revenue Growth
- STAA N/A
- DFIN N/A
- 52 Week Low
- STAA $13.50
- DFIN $37.80
- 52 Week High
- STAA $49.86
- DFIN $71.01
- Technical
- Relative Strength Index (RSI)
- STAA 49.02
- DFIN 72.40
- Support Level
- STAA $16.52
- DFIN $63.48
- Resistance Level
- STAA $18.00
- DFIN $66.25
- Average True Range (ATR)
- STAA 0.69
- DFIN 1.24
- MACD
- STAA 0.09
- DFIN 0.09
- Stochastic Oscillator
- STAA 53.85
- DFIN 71.79
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.